Skip to main content
logo
Avalyn Pharma Inc. (AVLN)
NASDAQ: AVLN · Real-Time Price · USD
28.19
+2.14 (8.24%)
Oct 26, 2026, 12:19 PM EDT - Market open

Avalyn Pharma Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Cash & Equivalents
264.252.3223.96
Short-Term Investments
88.2386.0986.68
Cash & Short-Term Investments
352.43138.41110.63
Cash Growth
-25.11%-
Other Receivables
1.670.540.59
Receivables
1.670.540.59
Prepaid Expenses
1.610.710.31
Other Current Assets
2.283.912.86
Total Current Assets
357.99143.56114.39
Property, Plant & Equipment
3.352.320.09
Long-Term Investments
61.1-7.49
Other Long-Term Assets
3.0132.55
Total Assets
425.45148.88124.52

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Accounts Payable
2.653.762.28
Accrued Expenses
7.359.896.47
Current Portion of Leases
0.820.44-
Total Current Liabilities
10.8114.098.74
Long-Term Leases
1.491.23-
Total Liabilities
27.115.328.74

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Common Stock
0.070.020.01
Additional Paid-In Capital
719.5426.555.43
Retained Earnings
-321.17-265.36-180.16
Comprehensive Income & Other
-0.10.130.2
Total Common Equity
398.35-238.66-174.52
Shareholders' Equity
398.35133.57115.78
Total Liabilities & Equity
425.45148.88124.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Jun '26 Dec '25 Dec '24
Total Debt
17.111.67-
Net Cash (Debt)
396.42136.74118.12
Net Cash Growth
-15.76%-
Net Cash Per Share
47.34140.82437.25
Filing Date Shares Outstanding
44.331.230.28
Total Common Shares Outstanding
44.331.230.28
Working Capital
347.18129.47105.64
Book Value Per Share
8.99-194.47-630.46
Tangible Book Value
398.35-238.66-174.52
Tangible Book Value Per Share
8.99-194.47-630.46
Machinery
0.440.160.11
Construction In Progress
-0.68-
SEC Filings: 10-K · 10-Q